An Analytical Study of Rare-Type Parkinsonism: A Proposed Therapeutic Approach Through a Combination of Medicines

Rare or atypical forms of Parkinsonism are associated with complex neurodegenerative mechanisms, including the accumulation and aggregation of misfolded alpha-synuclein proteins. These protein aggregates may interfere with normal neuronal function and dopamine regulation. One proposed mechanism involves the downregulation of vesicular monoamine transporter 2 (VMAT2), resulting in impaired dopamine storage within synaptic vesicles and increased cytosolic dopamine accumulation. Excess cytosolic dopamine may contribute to oxidative stress, potentially accelerating neuronal damage. The present study explores a proposed therapeutic approach involving Tarentula hispanica in combination with levadopa and carbidopa. The underlying hypothesis is that Tarentula hispanica may have a role in addressing alpha-synuclein-associated pathological processes, while levadopa and carbidopa support dopamine replacement. Entacapan, a catechol-O-methyltransferase (COMT) inhibitor, is also considered as a potential component of the proposed combination. A reported patient experiencing significant tremors associated with atypical Parkinsonism was initially treated with levadopa and carbidopa. Subsequently, Tarentula hispanica 30 was introduced as an additional preparation. Improvement in tremor severity was reported following the combined treatment. This study presents a preliminary hypothesis concerning a possible therapeutic combination. However, the proposed biological mechanisms and reported clinical observations require systematic laboratory investigation and controlled clinical evaluation before any therapeutic effectiveness can be established.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24414680
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

An Analytical Study of Rare-Type Parkinsonism: A Proposed Therapeutic Approach Through a Combination of Medicines

Tanujit Mondal, Arnab Maitra, Kausik Barik
Zenodo (CERN European Organization for Nuclear Research)
Parkinson's Disease Mechanisms and Treatments
article

An Analytical Study of Rare-Type Parkinsonism: A Proposed Therapeutic Approach Through a Combination of Medicines

Tanujit Mondal, Arnab Maitra, Kausik Barik
article en

Abstract

Rare or atypical forms of Parkinsonism are associated with complex neurodegenerative mechanisms, including the accumulation and aggregation of misfolded alpha-synuclein proteins. These protein aggregates may interfere with normal neuronal function and dopamine regulation. One proposed mechanism involves the downregulation of vesicular monoamine transporter 2 (VMAT2), resulting in impaired dopamine storage within synaptic vesicles and increased cytosolic dopamine accumulation. Excess cytosolic dopamine may contribute to oxidative stress, potentially accelerating neuronal damage. The present study explores a proposed therapeutic approach involving Tarentula hispanica in combination with levadopa and carbidopa. The underlying hypothesis is that Tarentula hispanica may have a role in addressing alpha-synuclein-associated pathological processes, while levadopa and carbidopa support dopamine replacement. Entacapan, a catechol-O-methyltransferase (COMT) inhibitor, is also considered as a potential component of the proposed combination. A reported patient experiencing significant tremors associated with atypical Parkinsonism was initially treated with levadopa and carbidopa. Subsequently, Tarentula hispanica 30 was introduced as an additional preparation. Improvement in tremor severity was reported following the combined treatment. This study presents a preliminary hypothesis concerning a possible therapeutic combination. However, the proposed biological mechanisms and reported clinical observations require systematic laboratory investigation and controlled clinical evaluation before any therapeutic effectiveness can be established.

Zenodo (CERN European Organization for Nuclear Research)
National Institute of Technical Teachers’ Training and Research (IN)
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
An Analytical Study of Rare-Type Parkinsonism: A Proposed Therapeutic Approach Through a Combination of Medicines — Tanujit Mondal, Arnab Maitra, et al. · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS